1.6K
Articles
47.8K
Citations
3.2
avg. Impact Factor
92
h-index

Most Cited Articles of Department of Oncology in 2005

TitleJournalYearCitations
Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: implications from age-period-cohort analysisCancer Epidemiology Biomarkers and Prevention2005109
Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinomaJournal of Biomedical Science200582
Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family proteinCancer Research200582
Identification and characterization of a novel gene Saf transcribed from the opposite strand of FasHuman Molecular Genetics200574
Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21)Blood200562
Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaBOncogene200557
Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver diseaseInternational Journal of Radiation Oncology Biology Physics200543
Early restaging whole-body (18)F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging200538
Inhibitors of epidermoid growth factor receptor suppress cell growth and enhance chemosensitivity of nasopharyngeal cancer cells in vitroOncology200537
Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylateHead and Neck200536
Primary breast lymphoma: a pooled analysis of prognostic factors and survival in 93 casesAnnals of Saudi Medicine200529
Effect of thalidomide in hepatocellular carcinoma: assessment with power doppler US and analysis of circulating angiogenic factorsRadiology200525
Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptorsWorld Journal of Gastroenterology200522
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancerOncology200517
Response of refractory osteosarcoma to thalidomide and celecoxibLancet Oncology, The200516
Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patientsWorld Journal of Gastroenterology200514
Expression of CD86 and increased infiltration of NK cells are associated with Helicobacter pylori-dependent state of early stage high-grade gastric MALT lymphomaWorld Journal of Gastroenterology200513
Gefitinib treatment for non-small cell lung cancer -- a study including patients with poor performance statusJournal of the Formosan Medical Association20058
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trialsLung Cancer20057
Docetaxel-induced recall dermatitis on previous laser treatment sitesBritish Journal of Dermatology20055
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and Paclitaxel as first-line treatmentOncology20054
Somatic mutations in epidermal growth factor receptor underlying complete responsiveness to gefitinib in a Taiwanese female patient with metastatic adenocarcinoma of lungAnti-Cancer Drugs20052
IN VITRO RELEASE OF HYDROCORTISONE BY GLYCINE-IMMOBILIZED EVAL MEMBRANEBiomedical Engineering - Applications, Basis and Communications20051